# Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery

> **NCT05702827** · PHASE3 · COMPLETED · sponsor: **TriHealth Inc.** · enrollment: 148 (actual)

## Conditions studied

- Stress Urinary Incontinence
- Surgical Incision
- Pain Vulva

## Interventions

- **DRUG:** Bupivacaine-Meloxicam

## Key facts

- **NCT ID:** NCT05702827
- **Lead sponsor:** TriHealth Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-23
- **Primary completion:** 2024-03-22
- **Final completion:** 2024-04-18
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05702827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05702827, "Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05702827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*